Inkwood Research released a research report, “Global CRISPR Market Forecast 2016-2022”
Global CRISPR Market – Synopsis
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is fragments of prokaryotic DNA containing short redundancies of base sequences. The global CRISPR Market is estimated to grow with an approximate CAGR of 35% during the forecasted period of 2016-2022.
Global CRISPR Market – Segmentation
The global CRISPR market is segmented on the basis of geographical analysis, product and end-user. The product segment is divided into design tools products, plasmids and vectors product and delivery system product. The end-user is further segmented into biotechnology companies, pharmaceutical companies, academic institutes and research and development institutes. Geographically, the market is segmented into North America, Europe, Asia Pacific, and the rest of the world.
Global CRISPR Market – Drivers
Increasing demand in drug discovery, late pregnancies leading to birth disorders, synthetic genes leading the way; aging genetic disorders and investment in path breaking research technology are the drivers for CRISPR Market. Drug discovery technology market plays a dominant role in boosting the CRISPR market.
Global CRISPR Market – Restraints
The possible misuse of CRISPR gene editing tool, slow growth and lack of healthcare budgets in developing countries are some of the restraints for CRISPR Market. CRISPR is linked with various applications such as Genome editing, genetic engineering etc. These applications are considered controversial due to the ethical concerns.
Global CRISPR Market – Competitive Landscape
Key players in the CRISPR markets focus on the innovations and advancements to proliferate the market growth. With newer advancements and technologies, the key players are strengthening their position in the market.
Global CRISPR Market – Key Players
The major market players for CRISPR market are Editas Medicine, Crispr Therapeutics Ag, Horizon Discovery Plc., Sigma-Aldrich, Genscript, Transposagen Biopharmaceuticals, Thermo Fisher Scientific, Caribou Biosciences, Inc., and Precision Biosciences among others.
